Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status

Medical and Pediatric Oncology

Volumn 31, Issue 1, 1998, Pages 1-7

  Kaneko, M ^a   Nishihira, H ^a   Mugishima, H ^a   Ohnuma, N ^a   Nakada, K ^a   Kawa, K ^a   Fukuzawa, M ^a   Suita, S ^a   Sera, Y ^a   Tsuchida, Y ^a  

^a Gumna Children S Medical Center   (Japan)

Author keywords

Chemotherapy; N myc amplification; Neuroblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; MELPHALAN; PIRARUBICIN; VINCRISTINE;

ADVANCED CANCER; ARTICLE; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUROBLASTOMA; ONCOGENE C MYB; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; WHOLE BODY RADIATION;

EID: 17344394998     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199807)31:1<1::AID-MPO1>3.0.CO;2-H     Document Type: Article

References (22)